1.Genetic Screening for Spinocerebellar Ataxia Genes in a Japanese Single-Hospital Cohort.
Ryuji SAKAKIBARA ; Fuyuki TATENO ; Masahiko KISHI ; Yohei TSUYUSAKI ; Yosuke AIBA ; Hitoshi TERADA ; Tsutomu INAOKA ; Setsu SAWAI ; Satoshi KUWABARA ; Fumio NOMURA
Journal of Movement Disorders 2017;10(3):116-122
OBJECTIVE: Diagnosis of sporadic cerebellar ataxia is a challenge for neurologists. A wide range of potential causes exist, including chronic alcohol use, multiple system atrophy of cerebellar type (MSA-C), and sporadic late cortical cerebellar atrophy. Recently, an autosomal-dominant spinocerebellar ataxia (SCA) mutation was identified in a cohort of patients with non-MSA-C sporadic cerebellar ataxia. The aim of this study is to genetically screen genes involved in SCA in a Japanese single-hospital cohort. METHODS: Over an 8-year period, 140 patients with cerebellar ataxia were observed. There were 109 patients with sporadic cerebellar ataxia (no family history for at least four generations, 73 patients with MSA-C, and 36 patients with non-MSA-C sporadic cerebellar ataxia) and 31 patients with familial cerebellar ataxia. We performed gene analysis comprising SCA1, 2, 3, 6, 7, 8, 12, 17, 31, and dentatorubro-pallidoluysian atrophy (DRPLA) in 28 of 31 non-MSA-C sporadic patients who requested the test. Familial patients served as a control. RESULTS: Gene abnormalities were found in 57% of non-MSA-C sporadic cerebellar ataxia cases. Among patients with sporadic cerebellar ataxia, abnormalities in SCA6 were the most common (36%), followed by abnormalities in SCA1 (7.1%), SCA2 (3.6%), SCA3 (3.6%), SCA8 (3.6%), and DRPLA (3.6%). In contrast, gene abnormalities were found in 75% of familial cerebellar ataxia cases, with abnormalities in SCA6 being the most common (29%). For sporadic versus familial cases for those with SCA6 abnormalities, the age of onset was older (69 years vs. 59 years, respectively), and CAG repeat length was shorter (23 vs. 25, respectively) in the former than in the latter (not statistically significant). CONCLUSION: Autosomal-dominant mutations in SCA genes, particularly in SCA6, are not rare in sporadic cerebellar ataxia. The reason for the frequency of mutations in SCA6 remains unclear; however, the reason may reflect a higher age at onset and variable penetrance of SCA6 mutations.
Age of Onset
;
Asian Continental Ancestry Group*
;
Atrophy
;
Cerebellar Ataxia
;
Cohort Studies*
;
Diagnosis
;
Family Characteristics
;
Genetic Testing*
;
Heredity
;
Humans
;
Multiple System Atrophy
;
Penetrance
;
Spinocerebellar Ataxias*
2.A Rare Case of Primary Squamous Cell Carcinoma of the Stomach and a Review of the 56 Cases Reported in Japan.
Hideyuki WAKABAYASHI ; Takeshi MATSUTANI ; Itsurou FUJITA ; Yoshikazu KANAZAWA ; Tsutomu NOMURA ; Nobutoshi HAGIWARA ; Masaru HOSONE ; Hironori KATAYAMA ; Eiji UCHIDA
Journal of Gastric Cancer 2014;14(1):58-62
We report an extremely rare case of primary squamous cell carcinoma of the stomach. A 69-year-old man was admitted to our hospital with a 2-month history of dysphagia and tarry stools. Endoscopic examination revealed a cauliflower-shaped protruding mass along the lesser curvature of the gastric cardia. Biopsy of the lesion revealed squamous cell carcinoma of the stomach. Computed tomography revealed a thickened stomach wall and a mass protruding into the gastric lumen. Total gastrectomy with splenectomy, distal pancreatectomy, and Roux-en-Y reconstruction was performed, together with a lower thoracic esophagectomy via a left thoracotomy. Histopathological examination of the specimen revealed well-differentiated squamous cell carcinoma of the stomach. Postoperative follow-up was uneventful for the first 18 months. However, multiple liver metastases and para-aortic lymph node metastasis developed subsequently. Despite systemic combination chemotherapy, the patient died because of progression of the recurrent tumors. Here, we review the characteristics of 56 cases of gastric squamous cell carcinoma reported in Japan.
Aged
;
Biopsy
;
Carcinoma, Squamous Cell*
;
Cardia
;
Deglutition Disorders
;
Drug Therapy, Combination
;
Esophagectomy
;
Follow-Up Studies
;
Gastrectomy
;
Humans
;
Japan*
;
Liver
;
Lymph Nodes
;
Neoplasm Metastasis
;
Pancreatectomy
;
Splenectomy
;
Stomach Neoplasms
;
Stomach*
;
Thoracotomy